Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 246

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 246
---
 | % |
| Malherbe Investments LLC(11)                                               |     |                           |          — |     |   |     — |   |     |            |  6,870,386 |     |   | 20.09 | % |     |            |  5.33 | % |
| ELL Investments, L.P.(12)                                                  |     |                           |  4,975,183 |     |   |  5.25 | % |     |            |          — |     |   |     — |   |     |            |  3.86 | % |
| Entities affiliated with ICONIQ Capital Management, LLC(13)                |     |                           |  9,009,594 |     |   |  9.51 | % |     |            |  5,030,000 |     |   | 14.71 | % |     |            | 10.89 | % |
| Brown Capital Management, LLC(14)                                          |     |                           |  7,873,643 |     |   |  8.31 | % |     |            |          — |     |   |     — |   |     |            |  6.11 | % |

| * | Represents less than one percent (1%). |

| (1) | Subject to the terms of the Operating Agreement, Enfusion OpCo’s Common Units are exchangeable for shares                                                           
 of Enfusion Common Stock on a one-for-one basis. Simultaneous with such exchange, a number of shares of Enfusion Class B Common Stock registered in the name of the 
 exchanging party will be canceled for no consideration on a one-for-one basis with the number of Common Units so exchanged. Beneficial ownership of Common Units    
 reflected in this table has not been also reflected as beneficial ownership of shares of Enfusion Common Stock for which such units may be exchanged.               |

| (2) | Represents percentage of voting power of the Enfusion Common Stock and Enfusion Class B Common Stock 
 voting together as a single class.                                                                   |

176

| (3) | Includes (a) 19,467 shares of Enfusion Common Stock directly held by Mr. Movchan, (b) 24,914 shares of                                                                                                                                       
 Enfusion Common Stock underlying Enfusion Stock Options directly held by Mr. Movchan that are or will become exercisable within 60 days of February 5, 2025, (